PRKN and hepatocellular carcinoma: In addition, we preliminarily demonstrated the potential antitumour mechanism underlying ailanthone, which involved mitochondrial dysfunction, mtDNA leakage-induced inflammatory response, and inhibition of PINK1-PRKN-mediated mitophagy, ultimately leading to HCC proliferation inhibition (Figure 8).